Researchers at the University of Colorado School of Medicine received a grant to study the genetic risk associated with thyroid cancer, potentially preventing unneeded biopsies and surgeries. By analyzing data from biobanks, they aim to create a polygenic risk score to better quantify the risk of thyroid cancer. This research could lead to personalized management of thyroid nodules, improved diagnosis, and reduced unnecessary procedures for patients. The goal is to determine if a biopsy or surgery is necessary based on individual genetic risk factors, potentially saving thousands of patients from undergoing unnecessary procedures and improving outcomes in thyroid cancer care.
Source link